Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BIOTRONIK-Safety and Clinical PerFormance of the Drug ELuting Orsiro Stent in the Treatment of Subjects With de Novo Coronary Artery Lesions-VI

NCT02870985 is registered in ClinicalTrials.gov with Biotronik (Beijing) Medical Device Ltd. as lead sponsor.

NCT NCT02870985
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02870985 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BIOTRONIK-Safety and Clinical PerFormance of the Drug ELuting Orsiro Stent in the Treatment of Subjects With de Novo Coronary Artery Lesions-VI
Lead sponsor
Biotronik (Beijing) Medical Device Ltd.
Phase
Not applicable
Overall status
Completed
Start date
July 14, 2015
Completion date
December 31, 2021
Enrollment
440 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease